Skip to content
Clinical Trials – home
Research site

University Hospitals Leuven

Belgium Herestraat 49, 3000 Leuven, Belgium, Leuven, Belgium

  • 5 trials recruiting
  • Acute myocardial infarction · Heart failure with preserved ejection fraction · Neuroblastoma
  • Adults and children

About Specializations

University Hospitals Leuven in Leuven, Belgium specialises in clinical trials of conditions such as Acute myocardial infarction, Heart failure with preserved ejection fraction, Neuroblastoma, Atrial fibrillation, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, particularly focusing on high-risk neuroblastoma. This complex and aggressive cancer primarily affects children, and the center is dedicated to improving treatment outcomes through innovative therapeutic strategies.

  • High-Risk Neuroblastoma Treatment
  • Chemoimmunotherapy Advancements
  • Radiotherapy Techniques

By conducting a randomized, international, and multicentric phase 3 study, the center evaluates and compares two treatment strategies across three therapeutic phases: induction, high-dose chemotherapy, and radiotherapy. This research introduces chemoimmunotherapy for patients with insufficient metastatic response after induction chemotherapy, aiming to enhance survival rates and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Herestraat 49, 3000 Leuven, BelgiumLeuvenBelgium
Recruiting now
5 trials
Conditions studied
8

More sites in LeuvenBelgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol
  • Sponsor:UZ Leuven
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Hamilton Health Sciences Corporation
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Noradrenaline Tartrate
  • Sponsor:Amsterdam UMC
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:ASST Grande Ospedale Metropolitano Niguarda
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.